- Staat
- MA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 21.04.2023
- Impfdatum
- 23.03.2023
- Beginn
- 11.04.2023
- Tage bis Beginn
- 19,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Fatigue
Headache
Pyrexia
Rash
Varicella virus test positive
Symptomtext
On 4/11 the patient started to have fatigue and HA. On 4/15 patient started to have rash, fever. 4/1823 patient tested positive for chicken pox.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- VZV PCR positive on 4/18/23
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 03.08.2022
- Impfdatum
- 26.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- UNK
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Gait disturbance
Injection site swelling
Irritability
Pyrexia
Rash
Urticaria
Symptomtext
pts mother called w/ complaints of hive like rash on 12mth old 3 days after receiving vaccines along with fever and fussiness. later that day pt had left knee swelling with difficulty walking.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,1
- Geschlecht
- F
- Eingang
- 16.05.2022
- Impfdatum
- 31.01.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site induration
Symptomtext
Reports leg redness and hardness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- Viral illness
- Vorgeschichte
- N/A
- Andere Medikamente
- None known
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 11.05.2022
- Impfdatum
- 09.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash pruritic
Symptomtext
Patient states the next day after receiving vaccinations that he broke out in a rash that itched. Patient appeared with a rash below elbow on each arm. Patient reported no allergies. Patient reported no redness or swelling at the site of the vaccinations. Patient was advised to follow up wit his primary care physician It is possible patient may have received previous vaccinations from another facility not recorded.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash pruritic
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 18.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash erythematous
Rash papular
Symptomtext
Pt. is 3 years of age. She was scheduled to receive her first dose of MMR, Varicella (Chicken Pox), and Hepatitis A vaccines. The Screening Checklist for Contraindications was reviewed. Pt. experienced a fever of 103?F after vaccines when she was an infant. It was treated with Tylenol. There were no other contraindications for vaccines today. Pt. was given the MMR vaccine SQ and the Hepatitis A vaccine IM in her Right Arm. The Varicella vaccine was given SQ in her Left Arm. Approximately 3 minutes after the vaccines were given, two pink raised areas approximately 3 mm diameter were noticed on her upper medial Left Arm. They both resembled pimples with a raised bright pink/red area in the center and fully surrounded by a flat pink area. She also had a few raised areas behind her Left Ear, one 3mm pink raised area on her upper left chest and back. She did not complain of any itching or discomfort. Pt. was monitored for 30 minutes. The raised area on her chest and area behind her ear resolved. There was another 5mm x 3mm area noted on the lumbar spine observed 20 minutes later. Mom was instructed to follow-up with her doctor regarding administration of an antihistamine. Pt. was not in any respiratory distress and mom was instructed to call EMS if she had any swelling of her lips, tongue, difficulty breathing. Mom verbalized understanding and left at 3:45 p.m. with symptoms improving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash erythematous
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- as an infant, pt experienced a fever of 103 following an infant vaccine. mom did not know the age/date/or which vaccine this was
- Staat
- AR
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 11.04.2022
- Impfdatum
- 10.03.2022
- Beginn
- 21.03.2022
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Burning sensation
Ear swelling
Erythema
Fatigue
Feeling hot
Inflammation
Peripheral swelling
Pruritus
Pyrexia
Urticaria
Symptomtext
3/21/2022 around 3:20 pm pt noticed redness and swelling in both hands. Both legs were itching and burning. Pt said legs felt like they were on fire. Then she noticed generalized hives all over body including face. She said her neck, face, and both ears were red. Her ears were red, swollen and hot to touch. Pt said she felt tired. She felt like she had fever but did not take her temperature. Denied swelling of lips, tongue, or throat. Denied having any SOB. Took Benadryl around 3:30 pm and all symptoms went away around 4 pm. Pt did not see a doctor for signs or symptoms. Father said they took child to ER but her symptoms were getting better so they did not stay to see the ER doctor. Pt showed me a picture of the hives on her arms and a picture of her neck and face that appeared red and inflamed. Referred pt to see her PCP regarding possible adverse reaction to vaccines. Pt received first set of childhood recommended vaccines on 3/10/2022. Father said child had not received childhood recommended vaccines before due to her brother had an anaphylaxis reaction to vaccines and nearly died. Father plans to take child to see APRN who is child's PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 10.03.2022
- Impfdatum
- 08.03.2022
- Beginn
- 10.03.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Discomfort
Erythema
Injection site warmth
Pain
Tenderness
Symptomtext
Patient presenting symptoms of bilateral redness and discomfort, reported to have pain on a 0-10 scale , reported a (3) when touch or scrap on objects. Patient reports of tender to touch. Upon assessment patient noted with warm to touch to site. Noted with redness to by lateral arms, measure 40 mm to left arm and 31 mm to right arm .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site warmth
- Hospital-Tage
- -
- Labordaten
- None done at this time.
- Aktuelle Erkrankungen
- None reported by patient nor mother .
- Vorgeschichte
- None reported.
- Andere Medikamente
- None reported by patient nor patient's mother.
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.07.2023
- Impfdatum
- 13.07.2023
- Beginn
- 13.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; A patient received an expired dose of the VARIVAX vaccine; This spontaneous report has been received from a medical assitant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported. On 13-JUL-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, (lot number U020244 was verified to be valid, expiration date reported and confirmed as 28-JUN-2023), administered as prophylaxis (exact dose, route of administration, and anatomical location were not provided) (Expired product administered). No additional adverse event (AE) nor product quality complaint (PQC) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse effects; VARIVAX was administered following temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. Concomitant medications included sterile diluent (STERILE DILUENT). On 01-JUN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot #U020244, expiration date: 28-JUN-2023, (strength and route of administration were not provided) for prophylaxis (Product storage error). On 15-MAY-2022, the varicella virus vaccine live (oka/merck) (VARIVAX) underwent temperature excursion at 6 degrees Fahrenheit (F) for 7 minutes. No previous temperature excursions were reported. No adverse events were reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 25.05.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse effects; VARIVAX was administered following temperature excursion; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 15-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) lot # U020244, expiration date 28-JUN-2023, 0.5 ml (route of administration and exact anatomical location were not reported) for prophylaxis (Product storage error). Administered dose of vaccine experienced a temperature excursion of 6 degrees Fahrenheit for 7 minutes. There were no previous excursions or additional adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.06.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse effects or symptoms following administration/No other AE; Caller is a medical assistant who reports VARIVAX was administered following temperature excursion.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. The patient's concomitant therapies included sterile diluent. On 16-MAY-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml, lot # U020244, expiration date 28-JUN-2023 (dose number, strength, route of administration and anatomical location were not provided) for prophylaxis (product storage error). It was unknown if patient sought medical attention or received any treatment for the event. The vaccine underwent temperature excursion of 6 Fahrenheit degrees for 7 minutes on 15-MAY-2022. There was no previous temperature excursions. No other adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.06.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Nurse calling for TE evaluation states dose of VARIVAX was administered to a patient. Temperature 8F for 16 hours; no additional AE details; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions were not reported. Concomitant medications included sterile diluent (MERCK STERILE DILUENT). On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot # U020244, expiration date: 28-JUN-2023, administered for prophylaxis (strength, exact dose and route of administration were not provided) (product storage error). Administered dose of vaccine experienced the temperature excursion of 8 degrees Fahrenheit for 16 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.06.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse event; Vaccine coordinator is reporting the administration of improperly stored vaccines to unknown patients after the temperature excursion on 20JAN202; This spontaneous report was received from an office manager referring to a patient of unspecified age and gender. The patient's concurrent conditions, medical history, and concomitant therapies were not reported. On 20-JAN-2022, temperature excursion occurred. The vaccine varicella virus vaccine live (Oka/Merck) (VARIVAX) exposed at a temperature of -14 degrees Celsius for 7 hours. On an unspecified date in 2022 (reported as after temperature excursion), the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, dose reported as 1 (units not reported) (strength, frequency, and route of administration were not provided); which lot # U020244 has been verified to be a valid lot number with expiration date: 28-JUN-2023, administered as prophylaxis (product storage error). It was unknown whether there was previous temperature excursion. No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2205USA005084:02167789 US-009507513-2205USA004997:02167739 US-009507513-2205USA005067:02167784 US-009507513-2205USA005023:02167763 US-009507513-2205USA004990:02167746 US-009507513-2205USA005071:02167774 US-009507513-2205USA005002:02167802 US-009507513-2205USA005130:02167643 US-009507513-2205USA005126:02167756 US-009507513-2205USA005002:02167797 US-009507513-2205USA005023:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.06.2022
- Impfdatum
- 02.06.2022
- Beginn
- 02.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
VARIVAX was administered following temperature excursion; No adverse effects or symptoms following administration; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications, and drug reactions or allergies was not provided by the reporter. On 15-MAY-2022, the vaccine underwent a temperature excursion of 6 Fahrenheit (F) for 7 minutes. There was no previous temperature excursion. Following the temperature excursion, on 02-JUN-2022, the patient received a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL, lot# U020244 with expiration date 28-JUN-2023 (strength and route of administration was not reported), administered for prophylaxis. No adverse effects or symptoms following administration. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001549: US-009507513-2206USA001318: US-009507513-2206USA001331: US-009507513-2206USA001347: US-009507513-2206USA001555: US-009507513-2206USA001558:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.06.2022
- Impfdatum
- 26.05.2022
- Beginn
- 26.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
VARIVAX was administered following temperature excursion.; No adverse effects or symptoms following administration; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications, and drug reactions or allergies was not provided by the reporter. On 15-MAY-2022, the vaccine underwent a temperature excursion of 6 Fahrenheit (F) for 7 minutes. There was no previous temperature excursion. Following the temperature excursion, on 26-MAY-2022, the patient received a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL, lot# U020244 with expiration date 28-JUN-2023 (strength and route of administration was not reported), administered for prophylaxis. No adverse effects or symptoms following administration. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2206USA001561: US-009507513-2206USA001549: US-009507513-2206USA001318: US-009507513-2206USA001331: US-009507513-2206USA001347: US-009507513-2206USA001555:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.06.2022
- Impfdatum
- 23.05.2022
- Beginn
- 23.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
VARIVAX was administered following temperature excursion.; No adverse effects or symptoms following administration; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications, and drug reactions or allergies was not provided by the reporter. On 15-MAY-2022, the vaccine underwent a temperature excursion of 6 Fahrenheit (F) for 7 minutes. There was no previous temperature excursion. Following the temperature excursion, on 23-MAY-2022, the patient received a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL, lot# U020244 with expiration date 28-JUN-2023 (strength and route of administration was not reported), administered for prophylaxis. No adverse effects or symptoms following administration. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001549: US-009507513-2206USA001561: US-009507513-2206USA001318: US-009507513-2206USA001331: US-009507513-2206USA001347: US-009507513-2206USA001558:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.06.2022
- Impfdatum
- 27.05.2022
- Beginn
- 15.05.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse effects or symptoms following administration; VARIVAX was administered following temperature excursion.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications, and drug reactions or allergies was not provided by the reporter. On 15-MAY-2022, the vaccine underwent a temperature excursion of 6 Fahrenheit (F) during 7 minutes. There was no previous temperature excursion. Following the temperature excursion, on 27-MAY-2022, the patient received a dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL, lot# U020244 with expiration date 28-JUN-2023 (strength and route of administration was not reported), administered for prophylaxis. No adverse effects or symptoms following administration.; Sender's Comments: US-009507513-2206USA001318: US-009507513-2206USA001331: US-009507513-2206USA001347: US-009507513-2206USA001555: US-009507513-2206USA001558: US-009507513-2206USA001561:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 14.06.2022
- Impfdatum
- -
- Beginn
- 20.01.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse event; Vaccine coordinator is reporting the administration of improperly stored vaccines to unknown patients after the temperature excursion on 20JAN2022.; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies, and concomitant therapies were not reported. On 20-JAN-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) dose 1, lot #U020244, expiration date: 28-JUN-2023, (strength, route of administration and anatomical location were not provided) that underwent a temperature excursion in -14 degree Celsius (C) for 7 hours (Product storage error). No additional adverse event (AE) was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2205USA004997:02167739 US-009507513-2205USA005084:02167789 US-009507513-2205USA005067:02167643 US-009507513-2205USA005130:02167643 US-009507513-2205USA004990:02167746 US-009507513-2205USA005126:02167756 US-009507513-2205USA005023:02167763 US-009507513-2205USA005071:02167774 US-009507513-2205USA005229:02167797
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2022
- Impfdatum
- -
- Beginn
- 20.01.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
administration of improperly stored vaccines to unknown patients after the temperature; no adverse event; This spontaneous report has been received from an office manager (vaccine coordinator) concerning a patient of unknown gender and age. The patient's drug reactions or allergies, concomitant therapies, medical history, and concurrent conditions were not provided. On 20-JAN-2022, varicella virus vaccine live (Oka/Merck) (VARIVAX), first dose (formulation, strength, dose vaccination scheme, route of administration, and anatomical site of vaccination were not reported, lot Number U020244, which has been verified to be valid, expiration date reported and validated as 28-JUN-2023), for prophylaxis; underwent a temperature excursion. The vaccine administered was stored at temperature of -14 degrees Celsius (C) during a time frame of 7 hours. It was unknown if a previous temperature excursion occurred or if a data logger was used. On an unspecified date in 2022, an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (Improper storage of product in use) was administrated to the patient. No additional adverse event was provided. This was one of eight reports received from the same reporter.; Sender's Comments: US-009507513-2205USA004997: US-009507513-2205USA005067:02167774 US-009507513-2205USA005084:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 07.06.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Administration of improperly stored vaccines to unknown patients after the temperature excursion; No adverse event; This spontaneous report was received from an office manager referring to a patient of unspecified age and gender. The patient's concurrent conditions, medical history, and concomitant therapies were not reported. On 20-JAN-2022, temperature excursion occurred. On an unspecified date in 2022 (reported as after temperature excursion), the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, (strength, dose, frequency, and route of administration were not provided); which lot # U020244 has been verified to be a valid lot number with expiration date: 28-JUN-2023, administered as prophylaxis. The temperature excursion occurred at a temperature of -14 degrees Celsius for 7 hours (product storage error). No previous temperature excursion was reported. No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2205USA004997: US-009507513-2205USA005067:02167789 US-009507513-2205USA005130: US-009507513-2205USA004990: US-009507513-2205USA005126: US-009507513-2205USA005023: US-009507513-2205USA005071: US-009507513-2205USA005229: US-009507513-2205USA005002:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.05.2022
- Impfdatum
- -
- Beginn
- 20.01.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; Vaccine coordinator is reporting the administration of improperly stored vaccines to unknown patients after the temperature excursion on 20-JAN-2022; This spontaneous report has been received from a vaccine coordinator concerning a patient of unreported age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On 20-JAN-2022, the patient was administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) (valid lot number U020244 [expiration date 28-JUN-2023]) for prophylaxis, after a temperature excursion of -14 degrees Celsius (C) for 7 hours (h) (product storage error) (dose number, vaccination scheme frequency, route, and anatomical location of vaccination were not provided). No previous temperature excursion was reported. No additional adverse events (AE) were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2205USA005023:02167763 US-009507513-2205USA004990:02167746 US-009507513-2205USA005084:02167789 US-009507513-2205USA005071:02167774 US-009507513-2205USA005002:02167802 US-009507513-2205USA004997:02167739 US-009507513-2205USA005229:02167797 US-009507513-2205USA005130:02167643 US-009507513-2205USA005126:02167756
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,1
- Geschlecht
- U
- Eingang
- 05.03.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; Nurse reporting a dose of improperly stored VARIVAX has been administered to a patient on 18JAN2022; This spontaneous report was received from a registered nurse and refers to a 13-month-old patient of unknown gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided. On 18-JAN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter (route of administration was not reported, lot # U020244 and expiration date 28-JUN-2023 administered as prophylaxis. The improperly stored dose of the suspect vaccine experienced a temperature excursion of 6 degree fahrenheit (?f) up to 14?F (31.8?F) for 1 hour an 45 minutes, and 14?F up to 46?F (14.4?F) for 25 minutes; no previous temperature excursions were reported. No adverse symptoms were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 05.03.2022
- Impfdatum
- 28.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; Nurse reporting a dose of improperly stored VARIVAX has been administered to a patient on 28JAN2022; This spontaneous report was received from a registered nurse and refers to a 12-months-old patient of unknown gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided. On 28-JAN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter (route of administration was not reported, lot # U020244 and expiration date 28-JUN-2023 administered as prophylaxis. The improperly stored dose of the suspect vaccine experienced a temperature excursion of 6 degree fahrenheit (?f) up to 14?F (13.8?F) for 1 hour an 45 minutes, and 14?F up to 46?F (14.4?F) for 25 minutes; no previous temperature excursions were reported. No adverse symptoms were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 05.03.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported.; Nurse reporting a dose of Improperly stored V ARIV AX has been administered; This spontaneous report was received from a registered nurse referring to a 12 month old patient of unreported gender. No information regarding the patient's pertinent medical history, drug reactions or allergies or concomitant therapies was provided. On 19-JAN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (product storage error) at a dose of 0.5 milliliter for prophylaxis (lot number U020244, expiration date 28-JUN-2023; route of administration, vaccination scheme frequency, concentration and anatomical location were not reported). It was later found that the administered dose of the vaccine experienced a temperature excursion of 6 Fahrenheit degrees up to 14 Fahrenheit degrees (13.8 Fahrenheit degrees) for 1 hour 45 minutes and 0 seconds and of 14 Fahrenheit degrees up to 46 Fahrenheit degrees (14.4 Fahrenheit degrees) for 0 hours 25 minutes and 0 seconds. There were no previous temperature excursions. No additional adverse events reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2202USA000685: US-009507513-2202USA000846:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,1
- Geschlecht
- U
- Eingang
- 17.02.2022
- Impfdatum
- 24.01.2022
- Beginn
- 24.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; Nurse reporting a dose of Improperly stored VARIVAX has been administered to a patient; This spontaneous report as received from registered nurse refers to a 13-month-old patient of unknown gender. The patient's pertinent medical history, concomitant medications, past drug reactions or allergies were not reported. On 24-JAN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml dose, lot # U020244, expiration date 28-JUN-2023 (route of administration and anatomical location were not reported) for prophylaxis (product storage error). The temperature excursion was from 6 Fahrenheit degree up to 14 (13.8) Fahrenheit degree for 1 hour 45 minutes and 14 Fahrenheit degree up to 46 (14.4) Fahrenheit degree for 25 minutes. No previous temperature excursions were reported. No additional adverse events reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- -
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 30.11.2021
- Beginn
- 30.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no further ae reported; Temp excursion reported 11/22/21; This spontaneous report was received from a nurse referring to a 25 years old, female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. Temperature excursion occurred on 22-NOV-2021. On 30-NOV-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously in the left arm (lot U020244, expiration date 28-JUN-2023) (strength and dose were not provided) and diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) intramuscularly in the right arm (lot C5787AA, expiration date 01-OCT-2023) (strength and dose were not provided). The temperature of storage and time frame of the excursion were 6? to 14? Fahrenheit (F) for 10 minutes and 14? to 46? F, for 3 hours respectively. If a digital data logger was involved was not reported. No adverse event. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2201USA003515:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- -
- Geschlecht
- F
- Eingang
- 12.02.2022
- Impfdatum
- 30.11.2021
- Beginn
- 30.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no further ae reported; Temp excursion occurred; This spontaneous report was received from a nurse referring to a 25 years old, female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. Temperature excursion occurred on an unspecified date. On 30-NOV-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously in the right arm (lot U020244, expiration date 28-JUN-2023) (strength and dose were not provided). The temperature of storage and time frame of the excursion were 6? to 14? Fahrenheit (F) for 10 minutes and 14? to 46? F, for 3 hours respectively. If a digital data logger was involved was not reported. No adverse event. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2201USA003515:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- -
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 03.12.2021
- Beginn
- 03.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no further ae reported; Temp excursion occurred; This spontaneous report was received from a nurse referring to a 24 years old, female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-DEC-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously, in the left arm (lot U020244, expiration date 28-JUN-2023) (strength and dose were not provided for any vaccine). The temperature of storage and time frame of the excursion were 6? to 14? Fahrenheit (F) for 10 minutes and 14? to 46? F, for 3 hours respectively. If a digital data logger was involved was not reported. No adverse event. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2201USA003515:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- -
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 24.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no further ae reported; product storage error temperature too high; This spontaneous report was received from a nurse referring to a 66 years old, female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. The vaccine was improperly stored on 22-NOV-2021 and on 24-NOV-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously, in the left arm (lot U020244, expiration date 28-JUN-2023) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneously, in the right arm (lot number T027914, expiration date 18-AUG-2022) (strength and dose were not provided for any vaccine). The temperature of storage and time frame of the excursion were 6? to 14? Fahrenheit (F) for 10 minutes and 14? to 46? F, for 3 hours respectively. If a digital data logger was involved was not reported. No adverse event. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2201USA003515:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- -
- Geschlecht
- F
- Eingang
- 11.02.2022
- Impfdatum
- 02.12.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Temp excursion occurred on 11/22/21; no further ae reported; This spontaneous report was received from a nurse referring to a 33 years old, female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. The vaccine was improperly stored on 22-NOV-2021 and on 02-DEC-2021, the patient was vaccinated with the improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneously, in the right arm (lot number U020244, expiration date 28-JUN-2023); and with influenza vaccine inact split 3v (FLULAVAL) intramuscularly in the left arm (lot number 3P3TX, expiration date 30-JUN-2023) (strength and dose were not provided). The temperature of storage and time frame of the excursion were 6? to 14? Fahrenheit (F) for 10 minutes and 14? to 46? F, for 3 hours respectively. If a digital data logger was involved was not reported. No adverse event. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2201USA003515:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; VARlVAX was administered after the excursion; This spontaneous report was received from a medical assistant and refers to a patient of an unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies was provided. Concomitant medications included sterile diluent (STERILE DILUENT). On 18-JAN-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 (units not provided) (lot #U020244, expiration date: 28-JUN-2023) (strength, frequency and route of administration were not provided) for prophylaxis. No adverse events were reported. According to the reporter, the temperature excursion was 30 degrees Fahrenheit for a time frame of 30 minutes on an unspecified date product storage error), without any previous temperature excursion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 07.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; a dose of Improperly Stored VARIVAX has been administered to a patient; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported. On 21-JAN-2022, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml (route not reported; lot #U020244, expiration date 28-JUN-2023) for prophylaxis (product storage error). The administered dose of the vaccine experienced a temperature excursion in the range 6 Fahrenheit degrees up to 14 Fahrenheit degrees (13.8 Fahrenheit degrees) for 1 hour 45 minutes and 0 seconds, and in the range 14 Fahrenheit degrees up to 46 Fahrenheit degrees (14.4 Fahrenheit degrees) for 0 hours 25 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 07.02.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; a dose of Improperly Stored VARIVAX has been administered to a patient; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported. On 25-JAN-2022, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml (route not reported; lot #U020244, expiration date 28-JUN-2023) for prophylaxis (product storage error). The administered dose of the vaccine experienced a temperature excursion in the range 6 Fahrenheit degrees up to 14 Fahrenheit degrees (13.8 Fahrenheit degrees) for 1 hour 45 minutes and 0 seconds, and in the range 14 Fahrenheit degrees up to 46 Fahrenheit degrees (14.4 Fahrenheit degrees) for 0 hours 25 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 07.02.2022
- Impfdatum
- 26.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; a dose of Improperly Stored VARIVAX has been administered to a patient; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported. On 26-JAN-2022, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml (route not reported; lot #U020244, expiration date 28-JUN-2023) for prophylaxis (product storage error). The administered dose of the vaccine experienced a temperature excursion in the range 6 Fahrenheit degrees up to 14 Fahrenheit degrees (13.8 Fahrenheit degrees) for 1 hour 45 minutes and 0 seconds, and in the range 14 Fahrenheit degrees up to 46 Fahrenheit degrees (14.4 Fahrenheit degrees) for 0 hours 25 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 07.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; a dose of Improperly Stored VARIVAX has been administered to a patient; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported. On 18-JAN-2022, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml (route not reported; lot #U020244, expiration date 28-JUN-2023) for prophylaxis (product storage error). The administered dose of the vaccine experienced a temperature excursion in the range 6 Fahrenheit degrees up to 14 Fahrenheit degrees (13.8 Fahrenheit degrees) for 1 hour 45 minutes and 0 seconds, and in the range 14 Fahrenheit degrees up to 46 Fahrenheit degrees (14.4 Fahrenheit degrees) for 0 hours 25 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.01.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; VARIVAX was administered after the excursion: 30 F for 30 min; This spontaneous report was received from medical assistant (office manager) and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-JAN-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U020244, expiration date: 28-JUN-2023, (dosing schedule and route of administration were not reported) for prophylaxis. Administered dose of vaccine was exposed to temperature 30 F for 30 minutes. No previous temperature excursion was noted. No additional adverse event (AE) was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.01.2022
- Impfdatum
- 21.12.2021
- Beginn
- 21.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
This spontaneous report was received from a healthcare business professional concerning a patient of unknown age. No information about the current condition, medical history or concomitant therapy was reported. There was previous temperature excursion of varicella virus vaccine live (oka/merck)(VARIVAX) and it was noted from 6 F to 14 F (5.7 F) for 11 minutes on 19-DEC-2021. On 20-DEC-2021, varicella virus vaccine live (oka/merck)(VARIVAX) was stored at 5.9 F for 13 minutes. On 21-DEC-2021, the patient was administered improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (dose and route were not reported; lot # U020244, expiry date: 28-JUN-2023) as prophylaxis (product storage error). The patient did not experience any adverse effects after this vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
